Zobrazeno 1 - 10
of 17
pro vyhledávání: '"valerie proulle"'
Autor:
Caterina Casari, Remi Favier, Paulette Legendre, Alexandre Kauskot, Frederic Adam, Veronique Picard, Peter J. Lenting, Cecile V. Denis, Valerie Proulle
Publikováno v:
Therapeutic Advances in Hematology, Vol 13 (2022)
This report describes the first case of splenic injury in a patient with p.V1316M-associated von Willebrand disease type 2B (VWD2B) with chronic thrombocytopenia, successfully treated with nonoperative management including von Willebrand factor (VWF)
Externí odkaz:
https://doaj.org/article/f46a35a8466e49af9e0fca1439be9097
Autor:
Berenice Schell, Celine Desconclois, Xavier Mariette, Cecile Goujard, Peter J. Lenting, Cecile V. Denis, Valerie Proulle
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/6272e7e6041c40748b5821b9a1e410c2
Autor:
Melissa Bou-Jaoudeh, Sandrine Delignat, Victoria Daventure, Jan Astermark, Hervé Lévesque, Jordan D. Dimitrov, Claire Deligne, Valérie Proulle, Sébastien Lacroix-Desmazes
Publikováno v:
Haematologica, Vol 108, Iss 5 (2023)
Neutralizing anti-factor VIII (FVIII) antibodies, known as FVIII inhibitors, represent a major drawback of replacement therapy in persons with congenital hemophilia A (PwHA), rendering further infusions of FVIII ineffective. FVIII inhibitors can also
Externí odkaz:
https://doaj.org/article/9ef633a3841246aeb61a09081db47918
Autor:
Roseline D'Oiron, Antoine Rauch, Sandrine MEUNIER, Cecile Denis, Benoit Guillet, Yesim Dargaud, Sophie Susen, Sophie VOISIN, Yohann REPESSE, HERVE CHAMBOST, Claude Negrier, Michaela Fontenay, Jean-Christophe GRIS, Valerie Proulle, Anne Lienhart, Jean-Francois Schved, Valérie Chamouard
Publikováno v:
Medicine. 95:e3038
von Willebrand disease (VWD) is a genetic bleeding disease due to a defect of von Willebrand factor (VWF), a glycoprotein crucial for platelet adhesion to the subendothelium after vascular injury. VWD include quantitative defects of VWF, either parti
Autor:
Leigh Madden, Sophie Susen, Raj Kasthuri, Lisa Lincz, Françoise DIGNAT-GEORGE, Michael Harrison, Valerie Proulle, Marcelo De Carvalho Bittencourt
Publikováno v:
Europe PubMed Central
Autor:
Mc, Morel-Kopp, Kaplan C, valerie proulle, Jallu V, Melchior C, Peyruchaud O, Mh, Aurousseau, Kieffer N
Publikováno v:
Europe PubMed Central
Glanzmann's thrombasthenia (GT) is a recessive autosomal bleeding disorder characterized by abnormal platelet aggregation due to a qualitative or quantitative defect of the glycoprotein (GP) IIb-IIIa complex (integrin alphaIIb beta3). We describe a n
Autor:
Carine Farkh, Syrine Ellouze, Louis Gounelle, Mama Sad Houari, Jérôme Duchemin, Valérie Proulle, Michaela Fontenay, Xavier Delavenne, Georges Jourdi
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Direct oral factor Xa (FXa) inhibitors interfere with lupus anticoagulant (LA) assays challenging antiphospholipid syndrome diagnosis in treated patients. We evaluated a new device, called DOAC Filter, and its usefulness in this setting.
Externí odkaz:
https://doaj.org/article/b68bcf452eed45ec8d79b4da41113d27
Autor:
Véronique Picard, Corinne Guitton, Lamisse Mansour-Hendili, Bernard Jondeau, Laurence Bendélac, Maha Denguir, Julien Demagny, Valérie Proulle, Frédéric Galactéros, Loic Garçon
Publikováno v:
Frontiers in Physiology, Vol 11 (2021)
Gardos channelopathy (Gardos-HX) or type 2 stomatocytosis/xerocytosis is a hereditary hemolytic anemia due to mutations in the KCNN4 gene. It is rarer than inherited type 1 xerocytosis due to PIEZO1 mutations (Piezo1-HX) and its diagnosis is difficul
Externí odkaz:
https://doaj.org/article/31491852c95e4e7a8d8a25a25a90446b
Autor:
Dong Wang, Yongshuai Yang, Yu Wang, Valérie Proulle, Peter A. Andreasen, Wanjin Hong, Zhuo Chen, Mingdong Huang, Peng Xu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110528- (2020)
Disseminated intravascular coagulation (DIC), an acute syndrome of systemic thrombus formation in microvasculatures throughout the body, can be induced by severe infections, e.g. sepsis. Anticoagulants are clinically used to alleviate the intensities
Externí odkaz:
https://doaj.org/article/49ec98a6b50548c985556437dea4d021
Autor:
Annabelle Dupont, Christelle Soukaseum, Mathilde Cheptou, Frédéric Adam, Thomas Nipoti, Marc-Damien Lourenco-Rodrigues, Paulette Legendre, Valérie Proulle, Antoine Rauch, Charlotte Kawecki, Marijke Bryckaert, Jean-Philippe Rosa, Camille Paris, Catherine Ternisien, Pierre Boisseau, Jenny Goudemand, Delphine Borgel, Dominique Lasne, Pascal Maurice, Peter J. Lenting, Cécile V. Denis, Sophie Susen, Alexandre Kauskot
Publikováno v:
Haematologica, Vol 104, Iss 12 (2019)
Patients with type 2B von Willebrand disease (vWD) (caused by gain-of-function mutations in the gene coding for von Willebrand factor) display bleeding to a variable extent and, in some cases, thrombocytopenia. There are several underlying causes of
Externí odkaz:
https://doaj.org/article/c6a2a981946540fc902c3cbea7dc27d8